Cargando…

Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study

BACKGROUND: Glucose metabolism after kidney transplantation (KT) is highly dynamic with the first post-transplantation year being the most critical period for new-onset diabetes after transplantation (NODAT) occurrence. The present study aimed to analyze dynamics of glucose metabolism and report inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Salah, Doaa M., Hafez, Mona, Fadel, Ftaina I., Selem, Yasmen Ahmed Said, Musa, Noha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842551/
https://www.ncbi.nlm.nih.gov/pubmed/35816203
http://dx.doi.org/10.1007/s00467-022-05669-0
_version_ 1784870158071758848
author Salah, Doaa M.
Hafez, Mona
Fadel, Ftaina I.
Selem, Yasmen Ahmed Said
Musa, Noha
author_facet Salah, Doaa M.
Hafez, Mona
Fadel, Ftaina I.
Selem, Yasmen Ahmed Said
Musa, Noha
author_sort Salah, Doaa M.
collection PubMed
description BACKGROUND: Glucose metabolism after kidney transplantation (KT) is highly dynamic with the first post-transplantation year being the most critical period for new-onset diabetes after transplantation (NODAT) occurrence. The present study aimed to analyze dynamics of glucose metabolism and report incidence/risk factors of abnormal glycemic state during the first year after KT in children. METHODS: Twenty-one consecutive freshly transplanted pediatric kidney transplant recipients (KTRs) were assessed for fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT) weekly for 4 weeks, then every 3 months for 1 year. RESULTS: Interpretation of OGTT test showed normal glucose tolerance (NGT) in 6 patients (28.6%) while 15 (71.4%) experienced impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) at any time point of monitoring. Seven patients had NODAT, for which three needed insulin therapy. Hyperglycemia onset was 7.8 ± 13.12 weeks (median (range) = 1 (0–24) week) after KT. Percent of patients with abnormal OGTT was significantly more than that of IFG (38.1% vs. 71.4%, p = 0.029). Patients with abnormal glycemic state had significantly elevated trough tacrolimus levels at 6 months (p = 0.03). Glucose readings did not correlate with steroid doses nor rejection episodes while positively correlating with tacrolimus doses at 3 months (p = 0.02, CC = 0.73) and 6 months (p = 0.01, CC = 0.63), and negatively correlating with simultaneous GFR at 9 months (p = 0.04, CC =  − 0.57). CONCLUSIONS: Up to two thirds of pediatric KTRs (71.4%) experienced abnormal glycemic state at some point with peak incidence within the first week up to 6 months after KT. OGTT was a better tool for monitoring of glucose metabolism than FPG. Abnormal glycemic state was induced by tacrolimus and adversely affected graft function. GRAPHICAL ABSTRACT: A higher resolution version of the Graphical abstract is available as Supplementary information. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05669-0.
format Online
Article
Text
id pubmed-9842551
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-98425512023-01-18 Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study Salah, Doaa M. Hafez, Mona Fadel, Ftaina I. Selem, Yasmen Ahmed Said Musa, Noha Pediatr Nephrol Original Article BACKGROUND: Glucose metabolism after kidney transplantation (KT) is highly dynamic with the first post-transplantation year being the most critical period for new-onset diabetes after transplantation (NODAT) occurrence. The present study aimed to analyze dynamics of glucose metabolism and report incidence/risk factors of abnormal glycemic state during the first year after KT in children. METHODS: Twenty-one consecutive freshly transplanted pediatric kidney transplant recipients (KTRs) were assessed for fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT) weekly for 4 weeks, then every 3 months for 1 year. RESULTS: Interpretation of OGTT test showed normal glucose tolerance (NGT) in 6 patients (28.6%) while 15 (71.4%) experienced impaired fasting glucose (IFG) and/or impaired glucose tolerance (IGT) at any time point of monitoring. Seven patients had NODAT, for which three needed insulin therapy. Hyperglycemia onset was 7.8 ± 13.12 weeks (median (range) = 1 (0–24) week) after KT. Percent of patients with abnormal OGTT was significantly more than that of IFG (38.1% vs. 71.4%, p = 0.029). Patients with abnormal glycemic state had significantly elevated trough tacrolimus levels at 6 months (p = 0.03). Glucose readings did not correlate with steroid doses nor rejection episodes while positively correlating with tacrolimus doses at 3 months (p = 0.02, CC = 0.73) and 6 months (p = 0.01, CC = 0.63), and negatively correlating with simultaneous GFR at 9 months (p = 0.04, CC =  − 0.57). CONCLUSIONS: Up to two thirds of pediatric KTRs (71.4%) experienced abnormal glycemic state at some point with peak incidence within the first week up to 6 months after KT. OGTT was a better tool for monitoring of glucose metabolism than FPG. Abnormal glycemic state was induced by tacrolimus and adversely affected graft function. GRAPHICAL ABSTRACT: A higher resolution version of the Graphical abstract is available as Supplementary information. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00467-022-05669-0. Springer Berlin Heidelberg 2022-07-11 2023 /pmc/articles/PMC9842551/ /pubmed/35816203 http://dx.doi.org/10.1007/s00467-022-05669-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Salah, Doaa M.
Hafez, Mona
Fadel, Ftaina I.
Selem, Yasmen Ahmed Said
Musa, Noha
Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
title Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
title_full Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
title_fullStr Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
title_full_unstemmed Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
title_short Monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
title_sort monitoring of blood glucose after pediatric kidney transplantation: a longitudinal cohort study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842551/
https://www.ncbi.nlm.nih.gov/pubmed/35816203
http://dx.doi.org/10.1007/s00467-022-05669-0
work_keys_str_mv AT salahdoaam monitoringofbloodglucoseafterpediatrickidneytransplantationalongitudinalcohortstudy
AT hafezmona monitoringofbloodglucoseafterpediatrickidneytransplantationalongitudinalcohortstudy
AT fadelftainai monitoringofbloodglucoseafterpediatrickidneytransplantationalongitudinalcohortstudy
AT selemyasmenahmedsaid monitoringofbloodglucoseafterpediatrickidneytransplantationalongitudinalcohortstudy
AT musanoha monitoringofbloodglucoseafterpediatrickidneytransplantationalongitudinalcohortstudy